Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |